DrugPatentWatch Database Preview
Pertuzumab - Biologic Drug Details
» See Plans and Pricing
Summary for pertuzumab
Tradenames: | 1 |
Patents: | 212 |
Applicants: | 1 |
BLAs: | 1 |
Suppliers: see list | 1 |
Recent Clinical Trials: | See clinical trials for pertuzumab |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for pertuzumab |
Recent Clinical Trials for pertuzumab
Identify potential brand extensions & biosimilar entrants
Sponsor | Phase |
---|---|
Breast International Group | Phase 2 |
Jules Bordet Institute | Phase 2 |
Institut Curie | Phase 2 |
Recent Litigation for pertuzumab
Identify key patents and potential future biosimilar entrants
District Court Litigation
Case Name | Date |
---|---|
CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD. | 2019-07-12 |
Genentech, Inc. v. Amgen Inc. | 2018-06-21 |
Genentech, Inc. v. Celltrion, Inc. | 2018-01-11 |
Pharmacology for pertuzumab
Mechanism of Action | HER2/Neu/cerbB2 Antagonists |
Patent Text Search: US Patents for pertuzumab
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Start Trial | Celgene Corporation (Summit, NJ) | 2039-02-26 | RX | search | |
Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Start Trial | Genentech, Inc. (South San Francisco, CA) | 2025-01-21 | RX | search | |
Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Start Trial | Genentech, Inc. (South San Francisco, CA) | 2025-05-20 | RX | search | |
Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Start Trial | Hoffmann-La Roche Inc. (Nutley, NJ) | 2025-08-12 | RX | search | |
Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Start Trial | Genentech, Inc. (South San Francisco, CA) | 2039-02-26 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for pertuzumab
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2016042164 | Start Trial |
Portugal | 2281006 | Start Trial |
Canada | 2859721 | Start Trial |
Hong Kong | 1198332 | Start Trial |
World Intellectual Property Organization (WIPO) | 2013063702 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for pertuzumab
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
02030011 | Spain | Start Trial | PRODUCT NAME: LAROTRECTINIB Y/O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, PARTICULARMENTE SULFATO DE LAROTRECTINIB QUE INCLUYE HIDROGENOSULFATO DE LAROTRECTINIB; NATIONAL AUTHORISATION NUMBER: EU/1/19/1385; DATE OF AUTHORISATION: 20190919; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/19/1385; DATE OF FIRST AUTHORISATION IN EEA: 20190919 |
2020000012 | Germany | Start Trial | PRODUCT NAME: LAROTRECTINIB UND/ODER ANDERE PHARMAZEUTISCH ANNEHMBARE SALZE DAVON, INSBESONDERE LAROTRECTINIBSULFATE UMFASSEND LAROTRECTINIBHYDROGENSULFAT; REGISTRATION NO/DATE: EU/1/19/1385 20190919 |
C00150 | Luxembourg | Start Trial | PRODUCT NAME: LAROTRECTINIB ET/OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, EN PARTICULIER LE SULFATE DE LAROTRECTINIB, Y COMPRIS L'HYDROGENOSULFATE DE LAROTRECTINIB; AUTHORISATION NUMBER AND DATE: EU/1/19/1385 20190923 |
20/009 | Ireland | Start Trial | PRODUCT NAME: LAROTRECTINIB AND/OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PARTICULARLY LAROTRECTINIB SULFATE INCLUDING LAROTRECTINIB HYDROGEN SULFATE; REGISTRATION NO/DATE: EU/1/19/1385 20190923 |
2015 | Austria | Start Trial | PRODUCT NAME: POMALIDOMID UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE, HYDRATE ODER STEREOISOMERE; REGISTRATION NO/DATE: EU/1/13/850 20130805 |
>Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |